Dr. Brian Druker is a renowned oncologist and researcher who has made significant contributions to the field of cancer treatment. He is best known for his pioneering work in the development of targeted cancer therapy, particularly for chronic myeloid leukemia (CML). Druker currently serves as the Director of the Knight Cancer Institute at Oregon Health & Science University (OHSU).
